The analysis revealed statistically significant correlations for survival post-tumor recurrence with the variables CD45+PD-L1+ (leukocyte cells positive for PD-L1) and CD45+CD11b+CD14+ PD-L1+ (TAMs positive for PD-L1). The gene discussed is ITGAM; the disease is neoplasm.